TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy.

Daniel P Petrylak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.